Medicine
Showing 41-60 of 79 Results
-
Annesa Flentje
Professor (Research) of Medicine (Stanford Prevention Research Center)
BioAnnesa Flentje, PhD, is a Professor at Stanford University in the Stanford Prevention Research Center, Department of Medicine, School of Medicine. Dr. Flentje is a clinical psychologist who uses multiple methods to understand the impacts of stress and coping on human health and disease. Her research has investigated how stress directly impacts health outcomes and how these processes are mediated through both behaviors (e.g., substance use and coping) and molecular mechanisms (e.g., epigenetics and transcriptional regulation). Dr. Flentje has developed cognitive behavioral interventions to reduce stress, and identified these as a mechanism to alter immune pathways in gene expression. Dr. Flentje is currently leading a large comparative effectiveness study of two interventions for posttraumatic stress symptoms among LGBTQIA+ populations in California. Dr. Flentje has developed and led nationwide mentoring initiatives to support health research of understudied populations and translational research to improve health. Dr. Flentje is Co-Director of The PRIDE Study (pridestudy.org), a national longitudinal cohort study of LGBTQIA+ individuals within the United States that has enrolled over 30,000 participants and is approaching 10 years of data collection.
-
Shawna Follis
Instructor, Epidemiology and Population Health
Affiliate, Med/SPRC - DivisionBioShawna Follis, PhD, MS, is an Instructor and K99 Fellow in Epidemiology, researching the risk factors of cardiometabolic diseases. She completed her postdoctoral training at Stanford, as a Propel Postdoctoral Scholar from 2021 to 2023 and a NIH T32 Postdoctoral Fellow from 2020 to 2021. She received her PhD in epidemiology at the University of Arizona and her master’s degree in anthropology from Purdue University.
-
James Ford
Professor of Medicine (Oncology) and of Genetics and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsMammalian DNA repair and DNA damage inducible responses; p53 tumor suppressor gene; transcription in nucleotide excision repair and mutagenesis; genetic determinants of cancer cell sensitivity to DNA damage; genetics of inherited cancer susceptibility syndromes and human GI malignancies; clinical cancer genetics of BRCA1 and BRCA2 breast cancer and mismatch repair deficient colon cancer.
-
Stephen P. Fortmann, MD
C.F. Rehnborg Professor in Disease Prevention, Emeritus
Current Research and Scholarly InterestsDr. Fortmann's interests include population-level (community) prevention of cardiovascular disease, the epidemiology and prevention of chronic diseases, and the effects of the built environment on health. He has conducted research projects addressing tobacco use cessation, tobacco control policy, the role of retail marketing on youth tobacco use, nutrition education, blood pressure control, and lipid disorders.
-
Virginia Fowkes
Senior Lecturer in Medicine (Family and Community Medicine)
Casual Employee, Medicine - Primary Care and Population HealthCurrent Research and Scholarly InterestsEvaluation of academic-community programs for health professionals in medically underserved areas
Training of health professionals for medically underserved areas/populations
Program development in medical education (Family Medicine and (AHECs)
National and state policy workforce development -
Michael B. Fowler, MBBS, FRCP
Professor of Medicine (Cardiovascular), Emeritus
Current Research and Scholarly InterestsAdrenergic nervous system; beta-adrenergic function in, heart failure; drugs in heart failure.
-
Andrea Fox
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioAndrea is a certified Physician Assistant who joined Stanford Health Care in 2019 to develop a comprehensive Fracture Liaison Service and bone health clinic championed by Dr. Michael Gardner, Trauma Orthopaedist. Andrea earned a Masters degree in Medical Science, Physician Assistant Studies and a Masters in Health Administration, both from the University of Missouri. She holds a current certification with the International Society of Clinical Densitometry and has completed her certificate trained as a fracture liaison clinician through the National Osteoporosis Foundation. She has a keen interest in educating primary care providers and the general public on the importance of early monitoring, risk factors and treatment for bone loss and the prevention and healing of fractures.
-
Aaron Frank
Affiliate, Department Funds
Resident in MedicineBioAaron Frank, MD is an Internal Medicine Resident Physician at Stanford Healthcare. He graduated with distinction in medical education innovation and was inducted into the AOA Medical Honor Society at UC Irvine School of Medicine. A prior television producer who worked with CNN, ABC, History, Discovery, HGTV, Food Network, Travel Channel, NBC, Vice, he is committed to innovate groundbreaking ways of incorporating new technology into medical education. He also is a co-executive director and co-Founder of Sewing For Lives, a 501(c)(3) nonprofit organization, and led a group of 2,500 worldwide volunteers in making over 250,000 masks for healthcare workers, police and fire departments, teachers, and students throughout the COVID-19 pandemic. At UC Irvine, he created over 50 physical exam instructional videos viewed by medical students and residents. In addition, he is a member of The Empathy Project at NYU with Jon LaPook, MD, Chief Medical Correspondent for CBS news.
-
Matthew Frank
Assistant Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Matthew Frank, MD, PhD, is an Assistant Professor of Medicine in the Division of Blood and Marrow Transplantation and Cellular Therapy at Stanford University. Dr. Frank predominantly cares for patients with high-risk lymphoma and other blood cancers. He is a lead investigator of clinical trials evaluating the safety and effectiveness of cancer treatments called chimeric antigen receptor (CAR ) T therapy for patients with lymphomas and leukemias. Dr. Frank’s research focuses on developing methods to identify patients who are at high risk for relapse or developing side-effects after receiving CAR T therapy and to understand why these relapses and side-effects occur.
